Health ❯ Clinical Research

Drug Efficacy

Clinical Trials Side Effects Phase Trials Weight Loss Studies Statistical Significance GLP-1 Weight Loss Solutions Weight Loss Medications Anxiety Treatment Studies Binding Affinity Cirrhosis Treatment Patient Outcomes HIV Treatment Placebo Effects Regulatory Affairs HIV Studies Alcohol Consumption Weight Loss

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

The move signals a push to differentiate in a crowded weight-loss market.

Structure Therapeutics' Oral GLP-1 Posts Up to 15% Placebo-Adjusted Weight Loss as Company Prepares Phase 3

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Albumin-PLGA Nanoparticles Enable Ultrahigh Drug Loading and Six-Month Stability